1.57
price down icon0.63%   -0.01
after-market After Hours: 1.62 0.05 +3.18%
loading

Galectin Therapeutics Inc Stock (GALT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
0.91%
9.648
9.561 9.166 9.003 10.34
Interest Income/Expense
24.20%
1.052
0.847 0.835 0.65 0.46
Operating Income/Loss
0.91%
-9.648
-9.561 -9.166 -9.003 -10.34
Nonoperating Income/Loss
322.25%
-1.841
-0.436 -1.262 -0.111 -1.185
Income/Loss From Continuing Operations Before Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Income/Loss From Continuing Operations After Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Net Income/Loss
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Preferred Stock Dividends And Other Adjustments
87.30%
0.008
0.063 -0.006 0.063 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Diluted Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Basic Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Diluted Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
87.30%
0.008
0.063 -0.006 0.063 -
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):